2. Aastrom Biosciences, Inc. ( ASTM): Engages in developing autologous cell therapies for the treatment of severe and chronic cardiovascular diseases. Market cap at $59.1M, most recent closing price at $1.35. Of the 6 analysts that have set a target price on the stock, the lowest price target stands at $1.65. This implies a potential upside of 22.22% from current levels around $1.35. Net institutional sales in the current quarter at -2.6M shares, which represents about 5.97% of the company’s float of 43.58M shares.
Contrarian Ideas: Hedge Funds Are Selling These 10 Stocks Trading Below Target Price
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts